0001213900-25-071392.txt : 20250804 0001213900-25-071392.hdr.sgml : 20250804 20250804164547 ACCESSION NUMBER: 0001213900-25-071392 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20250804 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20250804 DATE AS OF CHANGE: 20250804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Helix Acquisition Corp. II CENTRAL INDEX KEY: 0001869105 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41955 FILM NUMBER: 251181061 BUSINESS ADDRESS: STREET 1: C/O CORMORANT ASSET MANAGEMENT, LP STREET 2: 200 CLARENDON STREET, 52ND FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 857 702 0377 MAIL ADDRESS: STREET 1: C/O CORMORANT ASSET MANAGEMENT, LP STREET 2: 200 CLARENDON STREET, 52ND FLOOR CITY: BOSTON STATE: MA ZIP: 02116 8-K 1 ea0251413-8k425_helix2.htm CURRENT REPORT
false 0001869105 00-0000000 0001869105 2025-08-04 2025-08-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): August 4, 2025

 

HELIX ACQUISITION CORP. II

(Exact name of registrant as specified in its charter)

 

Cayman Islands   001-41955   N/A
(State or other jurisdiction
of incorporation)		   (Commission File Number)   (I.R.S. Employer
Identification No.)

 

Cormorant Asset Management LP

200 Clarendon Street, 52nd Floor

Boston, MA 02116

(Address of principal executive offices, including zip code)

 

(857) 702-0370

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☒ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A ordinary shares, par value $0.0001 per share   HLXB   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On August 4, 2025, Helix Acquisition Corp. II (“Helix” or the “Company”) held an extraordinary general meeting (the “Extraordinary General Meeting”). At the Extraordinary General Meeting, an aggregate of 19,407,670 (82.55%) of the Company’s issued and outstanding ordinary shares, consisting of 14,807,670 Class A ordinary shares, par value $0.0001 per share (the “Helix Class A Shares”), and 4,600,000 Class B ordinary shares, par value $0.0001 per share (the “Helix Class B Shares”), held of record as of June 30, 2025, the record date for the Extraordinary General Meeting, were present either in person or by proxy, which constituted a quorum. The shareholders voted on the following proposals at the Extraordinary General Meeting, each of which was described in more detail in the Company’s definitive proxy statement/prospectus, which was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on July 10, 2025 (File No. 333-288222) (the “Proxy Statement/Prospectus”). Any terms used but not defined herein have the meaning assigned thereto in the Proxy Statement/Prospectus.

 

1. The Business Combination Proposal. To approve, by ordinary resolution, the entry of Helix into the Business Combination Agreement, dated February 28, 2025 (as amended by Amendment No. 1 to the Business Combination Agreement, dated as of June 17, 2025, and as it may be amended, restated, supplemented or otherwise modified from time to time, the “Business Combination Agreement”), by and among Helix, Helix II Merger Sub, Inc. (“Merger Sub”), and TheRas, Inc. (d/b/a BridgeBio Oncology Therapeutics) (“BBOT”) (in the form attached to the Proxy Statement/Prospectus as Annex A), the consummation of the transactions contemplated by the Business Combination Agreement and the performance by Helix of its obligations thereunder. The Business Combination Proposal was approved. The final voting tabulation for this proposal was as follows:

 

FOR   AGAINST   ABSTAIN
17,311,423  

2,096,247

   0

 

2. The Domestication Proposal. To approve, by special resolution, that Helix be de-registered in the Cayman Islands pursuant to article 49 of the amended and restated memorandum and articles of association of Helix (the “Helix Articles”) and Part XII of the Cayman Islands Companies Act (As Revised) and transferred by way of continuation to Delaware as a corporation under the laws of the state of Delaware (the “Domestication”). The Domestication Proposal was approved. The final voting tabulation for this proposal was as follows:

 

FOR   AGAINST   ABSTAIN
4,600,000   0   0

  

3. Stock Issuance Proposal. To approve, by ordinary resolution, that, for the purposes of complying with the applicable provisions of Nasdaq Listing Rules 5635(a), (b) and (d), the issuance or potential issuance of (i) shares of PubCo Common Stock to the shareholders of Helix in the Domestication and stockholders of BBOT in the merger of Merger Sub with and into BBOT, with BBOT surviving the merger as a wholly-owned subsidiary of Helix (the “Merger”), pursuant to the Business Combination Agreement, (ii) shares of common stock of PubCo (“PubCo Common Stock”) to the PIPE Investors in the PIPE Investment pursuant to the Subscription Agreements, and (iii) any other issuances of PubCo Common Stock and securities convertible into or exercisable for PubCo Common Stock pursuant to subscription, purchase or similar agreements Helix has entered, or may enter, into prior to Closing, be approved in all respects. The Stock Issuance Proposal was approved. The final voting tabulation for this proposal was as follows:

 

FOR   AGAINST   ABSTAIN
17,311,423   2,096,247   0

 

1

 

4. The Organizational Documents Proposal. To approve, by special resolution, that the Helix Articles currently in effect be amended and restated by the deletion in their entirety and the substitution in their place of the proposed new certificate of incorporation of (the “PubCo Charter”) and the proposed new bylaws (the “PubCo Bylaws”, together with the PubCo Charter, the “PubCo Organizational Documents”) (in the form attached to the Proxy Statement/Prospectus as Annex I and Annex J, respectively) including, without limitation, the authorization of the change in authorized share capital as indicated therein, in each case effective upon the effectiveness of the Domestication. The Organizational Documents Proposal was approved. The final voting tabulation for this proposal was as follows:

 

FOR   AGAINST   ABSTAIN

17,311,423

   2,096,247   0

 

5. The Advisory Organizational Documents Proposals. To approve, by ordinary resolution, on a non-binding and advisory basis only, the following material differences between the Helix Articles and the PubCo Organizational Documents:

 

A. Proposal No. 5A: Authorized Shares. To change the authorized capital stock of Helix from (i) 500,000,000 Helix Class A Shares, 50,000,000 Helix Class B Shares and 5,000,000 preference shares, par value $0.0001 per share, to (ii) 500,000,000 shares of PubCo Common Stock and 10,000,000 shares of undesignated preferred stock. Advisory Organizational Documents Proposal 5A was approved. The final voting tabulation for this proposal was as follows:

 

FOR   AGAINST   ABSTAIN

16,526,833

   2,880,837   0

 

B. Proposal No. 5B: Exclusive Forum Provision. To adopt Delaware as the exclusive forum for certain stockholder litigation. Advisory Organizational Documents Proposal 5B was approved. The final voting tabulation for this proposal was as follows:

 

FOR   AGAINST   ABSTAIN

16,526,833

  

2,880,837

  

0

 

C. Proposal No. 5C: Adoption of Supermajority Vote Requirement to Amend the PubCo Organizational Documents. To require the affirmative vote of at least (i) two-thirds of the outstanding shares of capital stock entitled to vote to adopt, amend or repeal the PubCo Bylaws and (ii) a majority of PubCo’s then outstanding common stock (except where a lower threshold is provided by the Delaware General Corporation Law) for amendments to the PubCo Charter. Advisory Organizational Documents Proposal 5C was approved. The final voting tabulation for this proposal was as follows:

 

FOR   AGAINST   ABSTAIN

15,455,283

  

3,952,387

  

0

 

D. Proposal No. 5D: Removal of Directors. To permit the removal of a director only for cause and only by the affirmative vote of not less than two-thirds of the outstanding shares entitled to vote at an election of directors, voting together as a single class. Advisory Organizational Documents Proposal 5D was approved. The final voting tabulation for this proposal was as follows:

 

FOR   AGAINST   ABSTAIN

15,452,895

  

3,954,775

  

0

 

E. Proposal No. 5E: Action by Written Consent of Stockholders. To require stockholders to take action at an annual or special meeting and prohibiting stockholder action by written consent in lieu of a meeting. Advisory Organizational Documents Proposal 5E was approved. The final voting tabulation for this proposal was as follows:

 

FOR   AGAINST   ABSTAIN

16,524,445

  

2,883,225

  

0

 

2

 

F. Proposal No. 5F: Other Changes In Connection With Adoption of the PubCo Organizational Documents. To authorize (1) changing the corporate name from “Helix Acquisition Corp. II” to “BridgeBio Oncology Therapeutics, Inc.”, (2) making PubCo’s corporate existence perpetual, and (3) removing certain provisions related to Helix’s status as a blank check company that will no longer be applicable upon consummation of the Business Combination. Advisory Organizational Documents Proposal 5F was approved. The final voting tabulation for this proposal was as follows:

 

FOR   AGAINST   ABSTAIN

16,239,873

  

3,167,797

  

0

 

 

6. The Incentive Plan Proposal. To approve, by ordinary resolution, the BridgeBio Oncology Therapeutics, Inc. 2025 Stock Option and Incentive Plan, in the form attached to the Proxy Statement/Prospectus as Annex K. The Incentive Plan Proposal was approved. The final voting tabulation for this proposal was as follows:

 

FOR   AGAINST   ABSTAIN

15,452,895

  

3,954,775

  

0

 

7. The ESPP Proposal. To approve, by ordinary resolution, the BridgeBio Oncology Therapeutics, Inc. 2025 Employee Stock Purchase Plan, in the form attached to the Proxy Statement/Prospectus as Annex L. The ESPP Proposal was approved. The final voting tabulation for this proposal was as follows:

 

FOR   AGAINST   ABSTAIN

15,455,283

  

3,952,387

  

0

 

8. The Director Election Proposal. To approve, by ordinary resolution, that the persons named below be elected to serve on the PubCo board of directors until their respective successors are duly elected and qualified, effective upon the consummation of the Business Combination. The Director Election Proposal was approved. The final voting tabulation for this proposal was as follows:

 

   FOR  WITHHOLD 
Eli Wallace, Ph.D.  19,407,670  0 
Neil Kumar, Ph.D.  19,407,670  0 
Frank McCormick, Ph.D., F.R.S., D. Sc.  19,407,670  0 
Praveen Tipirneni, M.D.  19,407,670  0 
Michelle Doig  19,407,670  0 
Bihua Chen  19,407,670  0 
Raymond Kelleher, M.D., Ph.D.  19,407,670  0 
Jake Bauer, M.B.A.  19,407,670  0 

  

As there were sufficient votes at the time of the Extraordinary General Meeting to approve the adoption of the required proposals, the “Adjournment Proposal” as described in the Proxy Statement/Prospectus was not required and Helix did not call a vote on that proposal.

 

Additional Information and Where to Find it

 

As previously disclosed, Helix, BBOT and Merger Sub entered into the Business Combination Agreement, pursuant to which, subject to the satisfaction or waiver of the conditions therein, the parties thereto will consummate the Business Combination. Upon closing of the transaction, the company will be renamed “BridgeBio Oncology Therapeutics, Inc.” (“PubCo”). As described in this Current Report on Form 8-K (the “Current Report”), the Business Combination was submitted to a vote of shareholders of Helix. The Proxy Statement/Prospectus includes both the proxy statement of Helix and a prospectus of PubCo relating to the shares to be issued in connection with the Business Combination. Helix, BBOT and/or PubCo may also file other relevant documents regarding the Business Combination with the SEC. This Current Report does not contain all the information that should be considered concerning the Business Combination and other matters and is not intended to provide the basis for any investment decision or any other decision in respect of such matters. Before making any investment decision, Helix’s shareholders and other interested persons are urged to read the Proxy Statement/Prospectus and other documents filed in connection with the Business Combination, because these documents will contain important information about Helix, BBOT, PubCo and the Business Combination. Shareholders will also be able to obtain free copies of the Registration Statement, the Proxy Statement/Prospectus and other documents filed with the SEC, once available, without charge, at the SEC’s website located at www.sec.gov, or by directing a request to Helix Acquisition Corp. II, c/o Cormorant Asset Management, LP, 200 Clarendon Street, 52nd Floor, Boston, MA 02116.

 

3

 

Forward-Looking Statements

 

Certain statements included in this Current Report that are not historical facts are forward-looking statements. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of other financial and performance metrics and projections of market opportunity; expectations and timing related to the success, cost and timing of product development activities, including timing of initiation, completion and data readouts for clinical trials and the potential approval of BBOT’s product candidates, including the progress and results of the ONKORAS-101 and BREAKER-101 clinical trials and the expected dosing of the first patient with BBO-11818; the clinical and therapeutic potential of BBO-8520, BBO-10203 and BBO-11818; the size and growth potential of the markets for BBOT’s product candidates; the therapeutic and curative potential of BBOT’s product candidates; financing and other business milestones; potential benefits of the business combination; and expectations relating to the business combination, including the proceeds of the business combination and the financing and BBOT’s expected cash runway and the timing of the closing of the business combination. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of BBOT’s and Helix’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and may differ from assumptions. Many actual events and circumstances are beyond the control of BBOT and Helix. These forward-looking statements are subject to a number of risks and uncertainties, including changes in domestic and foreign business, market, financial, political, and legal conditions; the inability of the parties to successfully or timely enter into definitive agreements with respect to the business combination or consummate the business combination, including the risk that any regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions (such as any SEC statements or enforcements or other actions relating to SPACs) that could adversely affect the combined company or the expected benefits of the business combination, or the risk that the approval of the shareholders of Helix or any other condition to closing is not obtained; failure to realize the anticipated benefits of the business combination; risks relating to any legal proceedings that may be instituted against Helix, the combined company or others following the announcement of the business combination, risks relating to the uncertainty of the projected financial information with respect to BBOT and the combined company; risks related to the approval of BBOT’s product candidates and the timing of expected regulatory and business milestones; ability to negotiate definitive contractual arrangements with potential customers; the impact of competitive product candidates; ability to obtain sufficient supply of materials; global economic and political conditions; the effects of competition on BBOT’s future business; the amount of redemption requests made by Helix’s public shareholders; and those factors discussed in documents Helix has filed or will file with the SEC. Additional risks related to BBOT’s business include, but are not limited to: uncertainty regarding outcomes of BBOT’s ongoing clinical trials, particularly as they relate to regulatory review and potential approval for its product candidates; risks associated with BBOT’s efforts to commercialize its product candidates; BBOT’s ability to maintain its existing agreements with third parties and to negotiate and enter into new definitive agreements on favorable terms, if at all; the impact of competing product candidates on BBOT’s business; intellectual property-related claims; BBOT’s ability to attract and retain qualified personnel; and BBOT’s ability to source the raw materials for its product candidates.

 

If any of these risks materialize or Helix’s or BBOT’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that neither Helix or BBOT presently know or that Helix and BBOT currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Helix’s and BBOT’s expectations, plans, or forecasts of future events and views as of the date of this press release and are qualified in their entirety by reference to the cautionary statements herein. Helix and BBOT anticipate that subsequent events and developments will cause Helix’s and BBOT’s assessments to change. These forward-looking statements should not be relied upon as representing Helix’s and BBOT’s assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements. Neither Helix, BBOT, nor any of their respective affiliates undertake any obligation to update these forward-looking statements, except as required by law.

 

No Offer

 

This Current Report shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom, nor shall any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction be affected. Neither the SEC nor any securities commission of any other U.S. or non-U.S. jurisdiction has approved or disapproved of the business combination contemplated hereby or determined that this press release is truthful or complete. Any representation to the contrary is a criminal offense.

 

4

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: August 4, 2025

 

HELIX ACQUISITION CORP. II  
     
By: /s/ Bihua Chen  
  Name:  Bihua Chen  
  Title: Chairman and Chief Executive Officer  

 

5

 

 EX-101.SCH 2 hlxb-20250804.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 hlxb-20250804_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 4 hlxb-20250804_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.25.2
Cover
Aug. 04, 2025
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Aug. 04, 2025
Entity File Number 001-41955
Entity Registrant Name HELIX ACQUISITION CORP. II
Entity Central Index Key 0001869105
Entity Tax Identification Number 00-0000000
Entity Incorporation, State or Country Code E9
Entity Address, Address Line One 200 Clarendon Street
Entity Address, Address Line Two 52nd Floor
Entity Address, City or Town Boston
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02116
City Area Code 857
Local Phone Number 702-0370
Written Communications true
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class A ordinary shares, par value $0.0001 per share
Trading Symbol HLXB
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
XML 7 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 8 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.25.2 html 1 24 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://helixacquisitioncorp2.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ea0251413-8k425_helix2.htm hlxb-20250804.xsd hlxb-20250804_lab.xml hlxb-20250804_pre.xml http://xbrl.sec.gov/dei/2025 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ea0251413-8k425_helix2.htm": { "nsprefix": "HLXB", "nsuri": "http://helixacquisitioncorp2.com/20250804", "dts": { "inline": { "local": [ "ea0251413-8k425_helix2.htm" ] }, "schema": { "local": [ "hlxb-20250804.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd", "https://xbrl.sec.gov/country/2025/country-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" ] }, "labelLink": { "local": [ "hlxb-20250804_lab.xml" ] }, "presentationLink": { "local": [ "hlxb-20250804_pre.xml" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2025": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2025": 24 }, "report": { "R1": { "role": "http://helixacquisitioncorp2.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2025-08-04", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea0251413-8k425_helix2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-08-04", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea0251413-8k425_helix2.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentDescription", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AnnualInformationForm", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CityAreaCode", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CountryRegion", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentAccountingStandard", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentAnnualReport", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodStartDate", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentQuarterlyReport", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentRegistrationStatement", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentShellCompanyReport", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentTransitionReport", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine1", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine2", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine3", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCityOrTown", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCountry", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityExTransitionPeriod", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFileNumber", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFilerCategory", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityPrimarySicNumber", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityShellCompany", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntitySmallBusiness", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityVoluntaryFilers", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Extension", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LocalPhoneNumber", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "NoTradingSymbolFlag", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementTenderOffer", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12bTitle", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12gTitle", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityExchangeName", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityReportingObligation", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SolicitingMaterial", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "TradingSymbol", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "WrittenCommunications", "presentation": [ "http://helixacquisitioncorp2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 13 0001213900-25-071392-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-25-071392-xbrl.zip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end XML 14 ea0251413-8k425_helix2_htm.xml IDEA: XBRL DOCUMENT 0001869105 2025-08-04 2025-08-04 iso4217:USD shares iso4217:USD shares false 0001869105 00-0000000 8-K 2025-08-04 HELIX ACQUISITION CORP. II E9 001-41955 200 Clarendon Street 52nd Floor Boston MA 02116 857 702-0370 true false false false Class A ordinary shares, par value $0.0001 per share HLXB NASDAQ true false